3648 results for «2462»
3648 results
TAV-in-TAV cases
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this session to delve into the complexities and challenges of TAV-in-TAV procedures. Gain insights into various case studies, including a successful TAV-in-TAV with coronary protection, a case of CABG and TAV-in-TAV, TAVI in a patient with failed homograft and three previous sternotomies, and concurrent mitral...
Standardised implant technique with self-expandable valve
08 Feb 2025 – From PCR Tokyo Valves 2025
Don’t miss this PCR Tokyo Valves 2025 session replay, where leading experts share key techniques for simplifying and optimising TAVI procedures with the Evolut device. This session covers essential insights into safely performing procedures on patients with various anatomical types using the self-expandable valve, while emphasising...
How to optimise clinical outcomes with the latest generation intra-annular self-expandable TAVI device?
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest advancements in TAVI procedures with this PCR Tokyo Valves 2025 session replay, where leading experts share key strategies to enhance patient outcomes. This session explores how to select the optimal index valve for lifetime management, reduce pacemaker rates with the latest intra-annular self-expanding...
Lifetime management - First valve choice matters
08 Feb 2025 – From PCR Tokyo Valves 2025
In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.
Management of paravalvular leak
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this comprehensive session on the management of paravalvular leaks, a challenging complication following surgical or transcatheter valve replacements. Discover insights into managing post-operative pulmonary edema, percutaneous closure of left ventricular septal defects, and the nuances of mitigating recurrent paravalvular leaks. Dive into complex cases involving...
Future devices for structural heart interventions
08 Feb 2025 – From PCR Tokyo Valves 2025
Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.
Nightmare in TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Watch this session replay featuring two challenging cases: valve embolisation with a balloon-expandable valve and coronary obstruction with a self-expandable valve. Learn key lessons from the first case, including the importance of secure pacing, avoiding damage to the descending aorta while retrieving the embolised valve, and...
TAVI and coronary artery disease
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the complex interplay between TAVI and coronary artery disease in this comprehensive session. Explore the decision-making process for optimal sequencing of PCI and TAVI, and examine cases of acute myocardial infarction due to coronary embolism and delayed coronary obstruction following TAVI. Gain insights into...
High-risk TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...
M-TEER for secondary mitral regurgitation
08 Feb 2025 – From PCR Tokyo Valves 2025
Managing secondary mitral regurgitation with M-TEER requires a tailored approach. This PCR Tokyo Valves 2025 session explores key considerations for atrial functional MR and VFMR beyond COAPT criteria, helping you refine patient selection, procedural strategies, and post-treatment management through expert insights and real-world cases.
The value of WATCHMAN therapy - Who should we treat?
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...
Complex PCI in a TAVI patient - LIVE case
20 May 2025 – From EuroPCR 2025
An 84-year-old patient with a history of ischemic stroke in 2017, hypertension, diabetes, dyslipidemia, and a preserved LV function (63 %) presented with a severe symptomatic aortic stenosis. The coronary angiography revealed a severe and calcified stenosis of the distal left main.
Operators implanted an Edwards Sapien...
Novel tools and strategies for acute heart failure
20 May 2025 – From EuroPCR 2025
Explore novel mechanical circulatory support tools and strategies for acute heart failure management, including venoarterial ECMO with a customizable counter-pulsatile ventricular assist device, advanced Impella positioning techniques, mitral TEER for cardiogenic shock with mitral regurgitation, and the interplay between vasoactive and mechanical support in ischemic cardiogenic...
Peripheral artery disease: cutting-edge research and evidence
20 May 2025 – From EuroPCR 2025
Review cutting-edge research and evidence in peripheral artery disease, focusing on IVUS-guided endovascular therapy for femoropopliteal disease, evolving endovascular approaches for Leriche syndrome, predictors of adverse events post-transpedal angioplasty, and multicentre outcomes of distal radial access for radial artery recanalization.
TAVI in bicuspid aortic valve disease - LIVE Case
20 May 2025 – From EuroPCR 2025
A 79-year-old male patient with atrial fibrillation and RBBB on ECG presented with symptomatic severe bicuspid aortic stenosis. LV function was preserved, and coronary artery disease was noted in LAD and first diagonal. A 26 mm Sapien Ultra Resilia valve was implanted via dual femoral access,...
DCB-PCI in de novo lesions
20 May 2025 – From EuroPCR 2025
Evaluate the role of drug-coated balloon (DCB) angioplasty in de novo coronary lesions with a focus on vessel diameter effects, comparisons to drug-eluting stents for small non-complex lesions, management of unstented dissections, high bleeding risk scenarios, and optimal dual antiplatelet therapy durations.
Adressing complex anatomy in STEMI
20 May 2025 – From EuroPCR 2025
Address anatomical complexities in STEMI management through cases involving bilateral compromised coronary ostia due to aortic dissection, rare challenging STEMI presentations, coronary steal phenomena, diffuse atherosclerotic dissections in young patients, and aneurysmal coronary artery angioplasty in IgG4-related disease.
Stable CAD and multivessel disease
20 May 2025 – From EuroPCR 2025
This session delves into the management of stable coronary artery disease (CAD) with multivessel involvement. Learn how clinical and procedural factors influence revascularisation strategies, debate the merits of complete revascularisation, and explore decision-making processes between anatomical and functional approaches through illustrative cases and expert analysis.
Catheter-based treatment of pulmonary embolism
20 May 2025 – From EuroPCR 2025
Explore catheter-based interventions for pulmonary embolism, addressing high-risk and massive thrombus cases, management of severe complications, and clinical scenarios involving multiple concurrent challenges to optimize patient care and procedural success.
Best companion's case for complications for stable coronary artery disease PCI: episode 2
20 May 2025 – From EuroPCR 2025
Examine complex complication cases during stable coronary artery disease PCI with detailed analyses of iatrogenic coronary dissection, procedural challenges, IVUS-guided resolution, and innovative catheter techniques that highlight precision and adaptability in interventional cardiology.
